Austin Online

Auto-injectors Market Projected to Grow $3.2 Billion by 2026 | Key Players – Eli Lilly; Scandinavian Health Ltd.; AbbVie, Inc.; Biogen Idec; Mylan N.V.; Pfizer, Inc.; and Sanofi

 Breaking News
  • No posts were found

Auto-injectors Market Projected to Grow $3.2 Billion by 2026 | Key Players – Eli Lilly; Scandinavian Health Ltd.; AbbVie, Inc.; Biogen Idec; Mylan N.V.; Pfizer, Inc.; and Sanofi

Auto-injectors Market Projected to Grow $3.2 Billion by 2026 | Key Players - Eli Lilly; Scandinavian Health Ltd.; AbbVie, Inc.; Biogen Idec; Mylan N.V.; Pfizer, Inc.; and Sanofi

Grand View Research, Inc. – Market Research And Consulting.
The global auto-injectors market size was estimated at USD 767.7 million in 2018 and is anticipated to exhibit a CAGR of 19.5%

The global auto-injectors market size is expected to reach USD 3.18 billion by 2026, according to a new report by Grand View Research, Inc, exhibiting a CAGR of 19.5%. Rising incidence of anaphylactic shock and other diseases such as diabetes, rheumatoid, & multiple sclerosis along with increasing approvals of auto-injectors are impelling growth.

Increasing prevalence of life-threatening allergies and rising demand for these devices are expected to aid growth. As per the Food Allergy Research & Education, around 200, 000 people every year need emergency medical care for allergic food reactions.

In addition, increasing approvals are anticipated to drive growth. For instance, in August 2018, U.S. FDA approved the first generic epinephrine auto-injector of Teva Pharmaceuticals to treat emergency allergic reactions, including anaphylaxis. Generic versions of EpiPen Jr & EpiPen of 0.15 mg & 0.3 mg, respectively, are indicated for pediatric and adult patients weighing more than 33 pounds.

Request a Sample Copy of the Global Auto-injectors Market Research Report @

Moreover, manufacturers are also developing new products and innovative technologies, which is expected to propel market growth. For instance, in June 2018, AbbVie GK launched Humira, which is a fully human antitumor necrosis factor alpha monoclonal antibody formulation with lock function & injection start & end alerts as well as an inspection window and injects completely in 10 seconds. Demand for these devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are anticipated to make them more convenient and user-friendly. This is encouraging patients to adopt this technology for chronic illnesses.

U.S. auto-injectors market size, by type, 2015 - 2026 (USD million)

Further key findings from the study suggest: 

  • Disposable auto-injectors emerged as the largest segment owing to convenience and ease of use
  • Homecare settings accounted for largest share in end-use segment owing to increasing demand of products for daily administration of insulin
  • North America dominated the auto-injectors market with largest share in 2018. Increasing demand for new technologies along with advanced healthcare infrastructure is expected to boost market growth during the forecast period
  • Asia Pacific is expected to witness fastest growth during the forecast period owing to increasing number of diabetic patients
  • Some of the key players are Eli Lilly; Scandinavian Health Ltd.; AbbVie, Inc.; Amgen; Owen Mumford; Ypsomed; Teva Pharmaceutical; Biogen Idec; Mylan N.V.; Pfizer, Inc.; and Sanofi

Global auto-injectors market size, by end use, 2018 (%)

Have Any Query? Ask Our Experts @

Grand View Research has segmented the global auto-injectors market based on product type, disease indication, end use, and region:

Auto-injectors Product Type Outlook (Revenue, USD Million, 2015 – 2026)

  • Disposable Auto-Injectors
  • Reusable Auto-Injectors
    • Prefilled Auto-Injectors
    • Empty Auto-Injectors

Auto-injectors Disease Indication Outlook (Revenue, USD Million, 2015 – 2026)

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies

Auto-injectors End-use Outlook (Revenue, USD Million, 2015 – 2026)

  • Homecare Settings
  • Hospitals & Clinics
  • Ambulatory Surgical Centers

Auto-injectors Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Browse Related Report:

Orthobiologics Market:

Health Information Exchange Market:

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States